MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2024-25)
- Udyam number
- UDYAM-DL-02-0029961
Daywish Pharma Private Limited
Daywish Pharma Private Limited - trading in New Delhi, Delhi, India. FY 2026 financials & compliance.
Revenue · FY 2024
₹30.21 Lakh
▼ 14% YoY
Net loss · FY 2024
₹22,683
Net margin -0.8%
EBITDA · FY 2024
₹59,258
EBITDA margin 2%
Authorised capital
₹1 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Company age
11 yrs
Est. 2015
Directors on board
2
As per MCA filings
Active GSTINs
1
GST registered
About Daywish Pharma Private Limited
Data last updated:
Daywish Pharma Private Limited is a private limited company based in New Delhi, Delhi, India. It operates in the wholesale distribution segment of the trading and commerce sector. It was incorporated on 04 December 2015 and has been in existence for over 11 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U24233DL2015PTC288150. Its GSTIN is 07AAFCD6852K1ZB (Delhi).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Amit Tyagi and Bhupendra Choudhary.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Pvt No. 7 – 8 – 9 Basement Property No. 1/6 Industrial Area Kirti Nagar, New Delhi, Delhi, India – 110015.
As per the financials filed for FY 2024, the company reported a revenue of ₹30.21 Lakh, a decline of 14% compared to the previous year. For the same year it recorded a net loss of ₹22,683 (net margin -0.8%) and EBITDA of ₹59,258 (EBITDA margin 2%). Revenue has grown at a compounded annual rate (CAGR) of 16% over three years and 10% over five years.
Daywish Pharma Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-DL-02-0029961). The current compliance status is marked as compliant by the Registrar of Companies.
Company details
CIN U24233DL2015PTC288150
Registration Number 288150
Incorporation Date 04 December 2015
ROC Delhi
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
MSME Classification Micro
Udyam Registration UDYAM-DL-02-0029961
Key People
Amit Tyagi Director Bhupendra Choudhary Director Recognitions & Rankings of Daywish Pharma
Contact details
Daywish Pharma Private Limited's registered office is in New Delhi, Delhi. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressPvt No. 7 – 8 – 9 Basement Property No. 1/6 Industrial Area Kirti Nagar, New Delhi, Delhi, India – 110015
- IndustryTrading, Other Wholesale, Wholesale
To see the full contact details of Daywish Pharma Private Limited, buy the company report.
Comprehensive company report
Daywish Pharma Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Daywish Pharma is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Daywish Pharma Private Limited, buy the company report.
Financials of Daywish Pharma Private Limited
FY 2025 filings availableDaywish Pharma Private Limited reported revenue of ₹30.21 Lakh (down 14% YoY) for FY 2024.
Revenue · FY 2024
₹30.21 Lakh ▼ 14%
Net loss · FY 2024
₹22,683 margin -0.8%
EBITDA · FY 2024
₹59,258 margin 2%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▼ 14%
3 years · compounded
▲ 16%
5 years · compounded
▲ 10%
EBITDA CAGR growth
1 year
▲ 2%
3 years · compounded
▲ 10%
5 years · compounded
▲ 6%
Revenue fell 14% in the latest year, but over five years it has grown at a compounded annual rate (CAGR) of 10%. EBITDA rose 2% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹59,258 | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹22,683 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 2% | ||||
| Net Profit Margin | -0.8% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Daywish Pharma Private Limited, buy the company report.
Board of directors of Daywish Pharma Private Limited
Daywish Pharma has 2 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Amit Tyagi | Director | 04 Dec 2015 | 10 Years 10 Months | Current |
| Bhupendra Choudhary | Director | 09 Mar 2016 | 10 Years 7 Months | Current |
Peer comparison
Daywish Pharma Private Limited is compared with the 10 companies closest to it by revenue in the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Vihaarya Automation Private Limited | ₹30.23 Lakh (FY 2025) | -11.0% | Thane, Maharashtra, India | |||
| Sam Aqurovet Private Limited | ₹30.23 Lakh (FY 2024) | 137.0% | Baruipur, West Bengal, India | |||
| Maxelon Pharmaceuticals Private Limited | ₹30.23 Lakh (FY 2025) | 5.0% | Naini, Uttar Pradesh, India | |||
| Ushodaya Suppliers Private Limited | ₹30.22 Lakh (FY 2020) | -40.0% | Kolkata, West Bengal, India | |||
| Aayurmax Pharma Private Limited | ₹30.22 Lakh (FY 2020) | Pragpura, Rajasthan, India | ||||
| Daywish Pharma Private Limitedthis company | ₹30.21 Lakh (FY 2024) | -₹22,683 | -0.8% | -14.0% | New Delhi, Delhi, India | |
| Quickzart Private Limited | ₹30.21 Lakh (FY 2024) | Gurgaon, Haryana, India | ||||
| Siluck Hybrid Seeds Private Limited | ₹30.21 Lakh (FY 2025) | 4.0% | Deoli, Rajasthan, India | |||
| Ghed Fish and Farmers Producer Company Limited | ₹30.21 Lakh (FY 2025) | 5.0% | Panidhra, Gujarat, India | |||
| Virtual Dealer Private Limited | ₹30.21 Lakh (FY 2024) | -64.0% | Howrah, West Bengal, India | |||
| Soilagro Crop Science Private Limited | ₹30.21 Lakh (FY 2024) | 169.0% | Raipur, Chhattisgarh, India |
To see the full peer comparison of Daywish Pharma Private Limited, buy the company report.
Auditor
Daywish Pharma Private Limited is audited by G R & COMPANY for the financial year 2017.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| G R & COMPANY | FY 2017 | 030022N |
Shareholding
The shareholding of Daywish Pharma Private Limited is on record for 2 financial years, the latest being FY 2017, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2017 | FY 2016 |
|---|---|---|
| Promoters | ||
| Domestic institutional investors (DII) | ||
| Foreign institutional investors (FII) | ||
| Public | ||
| Others |
To see the full shareholding pattern of Daywish Pharma Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Daywish Pharma Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Daywish Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Daywish Pharma has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 07AAFCD6852K1ZB | Delhi | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Daywish Pharma Private Limited, buy the company report.
Recent activity
Daywish Pharma Private Limited has 4 board changes on record since 2015: 2 appointments and 2 cessations. The latest: Bhupendra Choudhary ceased to be Additional Director on 30 Sep 2016.
AGM
Daywish Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Daywish Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Delhi.
Ceased
Bhupendra Choudhary ceased to be Additional Director.
Ceased
Vijay Pal ceased to be Director.
Appointed
Bhupendra Choudhary was appointed as Director.
Appointed
Amit Tyagi was appointed as Director.
Incorporation
04 Dec 2015
Daywish Pharma Private Limited was registered on 04 Dec 2015 with Roc Delhi & aged 10 years 10 months as per MCA records.
Frequently asked questions
Daywish Pharma is an active private limited company based in New Delhi, Delhi, India. The company works in other wholesale, within the trading industry. It was incorporated on 04 December 2015 (11+ years old) and is registered under CIN U24233DL2015PTC288150.
Daywish Pharma has 2 current directors:
- Amit Tyagi - Director
- Bhupendra Choudhary - Director
The latest financial statements of Daywish Pharma on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2016 are in the company report.
The GSTIN of Daywish Pharma is 07AAFCD6852K1ZB, registered in Delhi.
The CIN (Corporate Identification Number) of Daywish Pharma is U24233DL2015PTC288150. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Daywish Pharma was incorporated on 04 December 2015, making it 11+ years old. It is registered with the Registrar of Companies, Delhi.
The peers of Daywish Pharma by revenue are Vihaarya Automation Private Limited, Sam Aqurovet Private Limited, Maxelon Pharmaceuticals Private Limited, Ushodaya Suppliers Private Limited, Aayurmax Pharma Private Limited and 5 more, all in the same principal business activity (wholesale trading).
Bhupendra Choudhary ceased to be Additional Director on 30 Sep 2016. Vijay Pal ceased to be Director on 10 Mar 2016. Bhupendra Choudhary was appointed as Director on 09 Mar 2016. Daywish Pharma has 4 board changes on record in total.
Yes, Daywish Pharma is registered as a micro enterprise under Udyam registration (number: UDYAM-DL-02-0029961).
The registered office of Daywish Pharma is at Pvt No. 7 – 8 – 9 Basement Property No. 16 Industrial Area Kirti Nagar, New Delhi, Delhi, India – 110015.
Daywish Pharma operates in the trading industry, in the other wholesale segment.